A Nonparametric Bayesian Approach to Estimating Malaria Prophylactic Effect After Two Treatments
DOI:
https://doi.org/10.6000/1929-6029.2013.02.02.01Keywords:
Bayesian clinical trial, conditional survival posterior, drug resistance, efficacy, recurrence time, uncomplicated malaria, sulfadoxine-pyrimethamineAbstract
Two treatment regimens for malaria are compared in their abilities to cure and combat reinfection. Bayesian analysis techniques are used to compare two typical treatment therapies for uncomplicated malaria in children under five years, not only in their power to resist recrudescence, but also how long they can postpone recrudescence or reinfection in case of failure. We present a new way of analysing this type of data using Markov Chain Monte Carlo techniques. This is done using data from clinical trials at two different centres. The results which give the full posterior distributions show that artemisinin-based combination therapy is more efficacious than sulfadoxine-pyrimethamine. It both reduced the risk of recrudescence and delayed the time until recrudescence.
References
Spiegelhalter DJ, Freedman LS, Parmar MKB. Bayesian approaches to randomized trials. J Roy Statist Soc Ser A 1994; 357-16. http://dx.doi.org/10.2307/2983527 DOI: https://doi.org/10.2307/2983527
Fisher LD. Comments on: Bayesian and frequentist analysis and interpretation of clinical trials. Control Clin Trials 1996; 17(5): 423-34. http://dx.doi.org/10.1016/S0197-2456(96)00043-8 DOI: https://doi.org/10.1016/S0197-2456(96)00043-8
Freedman L. Bayesian statistical methods. BMJ 1996; 313(7057): 569-70. http://dx.doi.org/10.1136/bmj.313.7057.569 DOI: https://doi.org/10.1136/bmj.313.7057.569
Woodworth GG. Biostatistics: A Bayesian Introduction. Wiley-Interscience 2004; vol. 499.
von Seidlein L, Milligan P, Pinder M, Bojang K, Anyalebechi C, Gosling R, et al. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. Lancet 2000; 355(9201): 352-57. http://dx.doi.org/10.1016/S0140-6736(99)10237-X DOI: https://doi.org/10.1016/S0140-6736(99)10237-X
Zwang J, Olliaro P, Barennes H, Bonnet M, Brasseur P, Bukirwa H, et al. Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis. Malar J 2009; 8(1): 203. http://dx.doi.org/10.1186/1475-2875-8-203 DOI: https://doi.org/10.1186/1475-2875-8-203
Mutabingwa TK. Artemisinin-based combination therapies (ACTs): Best hope for malaria treatment but inaccessible to the needy. Acta Trop 2005; 95(3): 305-15. http://dx.doi.org/10.1016/j.actatropica.2005.06.009 DOI: https://doi.org/10.1016/j.actatropica.2005.06.009
Mårtensson A, Strömberg J, Sisowath C, Msellem MI, Gil JP, Montgomery SM, et al. Efficacy of artesunate plus amodiaquine versus that ofartemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. Clin Infect Dis 2005; 41(8): 1079-86. http://dx.doi.org/10.1086/444460 DOI: https://doi.org/10.1086/444460
Mårtensson A, Ngasala B, Ursing J, Veiga MI, Wiklund L, Membi C, et al. Influence of consecutive-day blood sampling on polymerase chain reaction-adjusted parasitological cure rates in an antimalarial-drug trial conducted in Tanzania. J Infect Dis 2007; 195(4): 597-601. http://dx.doi.org/10.1086/510910 DOI: https://doi.org/10.1086/510910
Kum CK. Bayesian analysis of two malaria treatments and probability modeling of malaria parasite genotypes, (PhLic Thesis). Stockholm University 2009.
Greenhouse B, Dokomajilar C, Hubbard A, Rosenthal PJ, Dorsey G. Impactof transmission intensity on the accuracy of genotyping to distinguish recrudescence from new infection in antimalarial clinical trials. AAC 2007; 51(9): 3096-103. DOI: https://doi.org/10.1128/AAC.00159-07
Sowunmi A, Adewoye EO, Gbotosho GO, Happi CT, Sijuade A, Folarin OA, et al. Factors contributing to delay in parasite clearance in uncomplicated falciparum malaria in children. Malar J 2010; 9: 53. http://dx.doi.org/10.1186/1475-2875-9-53 DOI: https://doi.org/10.1186/1475-2875-9-53
White NJ. The parasite clearance curve. Malar J 2011; 10(1): 278. http://dx.doi.org/10.1186/1475-2875-10-278 DOI: https://doi.org/10.1186/1475-2875-10-278
Datta S. Estimating the mean life time using right censored data. Statist Methodol 2005; 2(1): 65-69. http://dx.doi.org/10.1016/j.stamet.2004.11.003 DOI: https://doi.org/10.1016/j.stamet.2004.11.003
Zhong M, Hess KR. Mean Survival Time from Right Censored Data. Collection of Biostatistics Research Archives–bepress 2009.
Ying G, Heitjan DF, Chen TT. Nonparametric prediction of event times in randomized Clinical trials. 2004; 1(4): 352-61. http://dx.doi.org/10.1191/1740774504cn030oa DOI: https://doi.org/10.1191/1740774504cn030oa
Demiris N, Lunn D, Sharples LD. Survival extrapolation using the poly-Weibull model. Stat Methods Med Res 2011; 0(0): 1-15. http://dx.doi.org/10.1177/0962280211419645 DOI: https://doi.org/10.1177/0962280211419645
Gbotosho GO, Okuboyejo TM, Happi CT, Sowunmi A. Recrudescent Plasmodium falciparum infections in children in an endemic area following artemisinin–based combination treatments: Implications for disease control. Asian Pac J Trop Dis 2011; 1(3): 195-202. http://dx.doi.org/10.1016/S2222-1808(11)60027-3 DOI: https://doi.org/10.1016/S2222-1808(11)60027-3
Box GEP, Tiao GC. Bayesian inference in statistical analysis. DTIC Document 1973.
Bernardo JM, Smith AFM. Bayesian theory. Meas Sci Technol 2001; 12(2): 221. http://dx.doi.org/10.1088/0957-0233/12/2/702 DOI: https://doi.org/10.1088/0957-0233/12/2/702
Gelman A, Carlin JB, Stern HS, Rubin DB. Bayesian data analysis. Chapman & Hall/CRC 2003. DOI: https://doi.org/10.1201/9780429258480
Spiegelhalter DJ, Abrams KR, Myles JP. Bayesian approaches to clinical trials and health-care evaluation. Wiley 2004; vol. 13. DOI: https://doi.org/10.1002/0470092602
Lesaffre E, Lawson AB. Introduction to Bayesian Inference. Bayesian Biostatistics 2012; pp. 122-124. DOI: https://doi.org/10.1002/9781119942412
Chin R, Lee BY. Principles and practice of clinical trial medicine.Academic Press 2008. DOI: https://doi.org/10.1016/B978-0-12-373695-6.00001-6
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2013 Cletus Kwa Kum, Daniel Thorburn, Gebrenegus Ghilagaber, Pedro Gil, Anders Björkman
This work is licensed under a Creative Commons Attribution 4.0 International License.
Policy for Journals/Articles with Open Access
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work
Policy for Journals / Manuscript with Paid Access
Authors who publish with this journal agree to the following terms:
- Publisher retain copyright .
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work .
